
Articles
-
4 days ago |
hitconsultant.net | Jasmine Pennic
What You Should Know: – Lucet, a behavioral health company providing tech-enabled services to health plans, employers, and providers, today announced its acquisition of Emcara Health (previously PopHealthCare, a GuideWell Company). Financial details of the acquisition were not disclosed. – Emcara Health is a national, value-based medical group focused on delivering home-based care to clinically complex and high-risk populations.
-
4 days ago |
hitconsultant.net | Jasmine Pennic
What You Should Know: – Zelis, a provider of healthcare technology solutions announced its acquisition of the assets of Medxoom, a mobile-first member experience platform, from Allied Benefit Systems, LLC, the largest independent third-party administrator (TPA) in the United States. Financial details of the acquisition were not disclosed.
-
4 days ago |
hitconsultant.net | Jasmine Pennic
What You Should Know: – Sutter Health today announced it has received an unprecedented $110M philanthropic gift from a long-standing anonymous donor—the largest single donation in the not-for-profit health system’s history. – The historic contribution is set to accelerate Sutter Health’s strategic expansion and innovation initiatives, reinforcing its vision to deliver high-quality, comprehensive, and accessible care to communities across Northern California.
-
5 days ago |
hitconsultant.net | Jasmine Pennic
What You Should Know: – Daya Ventures, a Swedish venture studio that has rapidly established itself by building femtech companies from scratch, today announced the first close of its ongoing funding round. – The company has successfully secured SEK 2 million of a total targeted SEK 8 million, with investments from high-profile backers from both Wall Street and Europe.
-
5 days ago |
hitconsultant.net | Jasmine Pennic
What You Should Know: – Oxford Cancer Biomarkers Ltd (OCB), a leader in molecular precision cancer diagnostic tests, has today announced a new partnership with Mira Precision Health Inc. – This collaboration aims to advance OCB’s proprietary ToxNav® test in the United States, a revolutionary precision oncology tool designed to identify patients at high risk of severe toxicity from common chemotherapy treatments.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →